Corporate Action27 Oct 2026, 10:51 am
Chintan Makhecha Acquires 8,00,000 Warrants in Chandra Bhagat Pharma
AI Summary
Chintan Vijay Makhecha has acquired 8,00,000 convertible warrants in Chandra Bhagat Pharma Limited through a preferential issue. These warrants are convertible into equity shares. Post-acquisition, Makhecha's holding will be 8,00,000 warrants, representing a significant portion of the total diluted share capital. The total equity shares capital before the acquisition was 75,45,056, and after the assumed full conversion of warrants, the total diluted share capital will be 1,41,45,056 equity shares.
Key Highlights
- Chintan Vijay Makhecha acquired 8,00,000 convertible warrants.
- Acquisition was via preferential allotment.
- Warrants are convertible into equity shares.
- Total diluted capital post-conversion will be 1,41,45,056 shares.
- Disclosure made under SEBI (Takeovers) Regulations, 2011.
Price Impact
More from CBPL